The medical community has observed a groundbreaking advancement in diabetes management with the emergence of copyright. This transformative medication, designated as a glucagon-like peptide-1 (GLP-1) receptor agonist, offers a novel approach to controlling blood sugar levels in individuals with type 2 diabetes. copyright operates by mimicking the a